Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Exchange Rate Effect (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Exchange Rate Effect data on record, last reported at $6667.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 98.26% year-over-year to $6667.0; the TTM value through Sep 2025 reached -$104320.0, down 123.89%, while the annual FY2024 figure was -$527168.0, 207.94% down from the prior year.
  • Exchange Rate Effect reached $6667.0 in Q3 2025 per GANX's latest filing, down from $260070.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $483249.0 in Q4 2023 and bottomed at -$480592.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $21815.2, with a median of $21723.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: tumbled 1251.69% in 2024, then skyrocketed 1881.94% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $64508.0 in 2021, then soared by 250.42% to $226051.0 in 2022, then soared by 113.78% to $483249.0 in 2023, then tumbled by 199.45% to -$480592.0 in 2024, then skyrocketed by 101.39% to $6667.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $6667.0 in Q3 2025, $260070.0 in Q2 2025, and $109535.0 in Q1 2025.